3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine | CAS No. 101968-85-8

Q: What regulatory guidelines apply to 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8)?

The compound 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) is regulated under multiple frameworks. It is subject to the REACH regulations in the EU, and may be covered by other national and international regulations depending on its intended use. Additionally, the FDA and EPA may have specific guidelines for its handling and disposal, especially if it is used in pharmaceuticals or agricultural products. Proper hazard communication including GHS classification should be adhered to for safe handling and storage.

Q: Are there alternatives to 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) in its synthesis?

Alternative reagents can be used in the synthesis of 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8). For example, other amino acids or derivatives with similar functional groups can serve as precursors. Common alternatives include various carboxylic acids and their derivatives, which can be converted to the desired product through different chemical reactions such as amidation or esterification. The selection of alternatives depends on the specific synthesis requirements and desired properties of the final product.

Q: What is the market or research trend for 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8)?

The market for 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) is currently driven by its applications in pharmaceuticals and research. Recent trends show an increasing interest in its use as a building block for synthesizing complex molecules and as a potential therapeutic agent. Research is focusing on its biological activity and potential as a drug candidate. Market dynamics indicate a steady demand, supported by ongoing developments in biotechnology and personalized medicine.

Q: How should waste containing 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) be handled?

Waste containing 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) should be handled according to local and international environmental regulations. Proper waste collection should be ensured, and the waste should be disposed of through professional waste disposal services. Incineration or other environmentally friendly methods can be used, depending on the local regulations and the nature of the waste. Precautions should be taken to prevent contamination and ensure safe handling to protect both human health and the environment.

3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine

Basic Information

View in Editor

CAS Number

101968-85-8

Molecular Formula

C11H22N2O3

Molecular Weight

230.31 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Physical State

No data available

Melting Point

No data available

Boiling Point

407.6°C at 760 mmHg

Flash Point

200.3±24.0 °C

Refractive Index

1.472

SMILES

View in Editor

O=C(NC(C)(C)C)N[C@@H](C(C)(C)C)C(=O)O

InChI

InChI=1S/C11H22N2O3/c1-10(2,3)7(8(14)15)12-9(16)13-11(4,5)6/h7H,1-6H3,(H,14,15)(H2,12,13,16)/t7-/m1/s1

InChIKey

RAAPXVRHYBAJQU-SSDOTTSWSA-N

LogP

1.5834

Topological Polar Surface Area

78.43 Å²

Hydrogen Bond Donor/Acceptor

3 / 5

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

(S)-2-(3-(tert-Butyl)ureido)-3,3-dimethylbutanoic acid
N-tert-Butylcarbamoyl-L-tert-leucine
N-[[(1,1-Dimethylethyl)Amino]Carbonyl]-3-Methyl-L-Valine
(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoic acid
<i>N<
(S)-2-[3-(tert-Butyl)ureido]-3,3-dimethylbutyric Acid
(2S)-2-(tert-butylaminocarbonylamino)-3,3-dimethylbutanoic acid
Boceprevir INT 2
L-Valine,N-[[(1,1-diMethylethyl)aMino]carbonyl]-3-Methyl-
(2S)-2-(tert-butylcarbaMoylaMino)-3,3-diMethyl-butanoic acid
N-tert-ButylcarbaMoyl-L-tert-leucine
(S)-2-(3-tert-butylureido)-3,3-diMethylbutanoic acid [
N-[[(1,1-DiMethylethyl)aMino]carbonyl]-3-Methyl-L-valine
(2S)-2-(tert-ButylaMinocarbonylaMino)-3,3-diMethylbutanoic Acid

MDL Number

MFCD12796012

FAQ

What regulatory guidelines apply to 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8)?

The compound 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) is regulated under multiple frameworks. It is subject to the REACH regulations in the EU, and may be covered by other national and international regulations depending on its intended use. Additionally, the FDA and EPA may have specific guidelines for its handling and disposal, especially if it is used in pharmaceuticals or agricultural products. Proper hazard communication including GHS classification should be adhered to for safe handling and storage.

Are there alternatives to 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) in its synthesis?

Alternative reagents can be used in the synthesis of 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8). For example, other amino acids or derivatives with similar functional groups can serve as precursors. Common alternatives include various carboxylic acids and their derivatives, which can be converted to the desired product through different chemical reactions such as amidation or esterification. The selection of alternatives depends on the specific synthesis requirements and desired properties of the final product.

What is the market or research trend for 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8)?

The market for 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) is currently driven by its applications in pharmaceuticals and research. Recent trends show an increasing interest in its use as a building block for synthesizing complex molecules and as a potential therapeutic agent. Research is focusing on its biological activity and potential as a drug candidate. Market dynamics indicate a steady demand, supported by ongoing developments in biotechnology and personalized medicine.

How should waste containing 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) be handled?

Waste containing 3-Methyl-N-[(2-methyl-2-propanyl)carbamoyl]-L-valine (CAS: 101968-85-8) should be handled according to local and international environmental regulations. Proper waste collection should be ensured, and the waste should be disposed of through professional waste disposal services. Incineration or other environmentally friendly methods can be used, depending on the local regulations and the nature of the waste. Precautions should be taken to prevent contamination and ensure safe handling to protect both human health and the environment.